BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 17682713)

  • 21. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Grandesso S; Sapino B; Mazzuccato S; Solinas M; Bedin M; D'Angelo M; Gion M
    Infez Med; 2012 Mar; 20(1):25-30. PubMed ID: 22475657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
    Passos XS; Costa CR; Araújo CR; Nascimento ES; e Souza LK; Fernandes Ode F; Sales WS; Silva Mdo R
    Mycopathologia; 2007 Mar; 163(3):145-51. PubMed ID: 17334813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea.
    Jung SI; Shin JH; Song JH; Peck KR; Lee K; Kim MN; Chang HH; Moon CS;
    Med Mycol; 2010 Jun; 48(4):669-74. PubMed ID: 20392145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
    Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
    Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
    Espinel-Ingroff A; Canton E; Gibbs D; Wang A
    J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
    Eksi F; Gayyurhan ED; Balci I
    ScientificWorldJournal; 2013; 2013():236903. PubMed ID: 24250260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D; Watelle M; Van der Flaes M; Nolard N
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
    Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
    J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
    Cocuaud C; Rodier MH; Daniault G; Imbert C
    J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
    Kawai A; Yamagishi Y; Mikamo H
    J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes.
    Sanitá PV; Mima EG; Pavarina AC; Jorge JH; Machado AL; Vergani CE
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Nov; 116(5):562-9. PubMed ID: 24055150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
    Aslan H; Gülmez D
    Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G; Carrillo-Muñoz AJ; Arévalo MP; Salgado J; Alonso-Vargas R; Rodrigo JM; Ruesga MT; Valverde A; Pemán J; Cantón E; Martín-Mazuelos E; Pontón J
    Chemotherapy; 2000; 46(6):395-401. PubMed ID: 11053905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.